AUS
NZ
UK
CA
USA
IND
Healthcare
Tooru (LSE:TOO) Secures GBP 3.9 Million Refinancing, Accelerates Brand Expansion Ahead of 2026
December 29, 2025 07:22 AM GMT| By Team Kalkine MediaHighlights,Tooru secured an expanded GBP 3.9 million debt facility with Shawbrook Bank, extended to 2030.,Pulsin products are set to expand distribution to 1,000 Co-op stores, up from 80 locations.,Juvela’s new OAF brand continues to progress, with d...
GSK Positioned at the Centre of FTSE 100 Healthcare Activity
December 29, 2025 05:24 AM GMT| By Vivek SinghDetailed discussion of GSK covering pharmaceutical operations, governance structure, and placement within major FTSE indices.
Verici Dx on FTSE AIM All Share Market Landscape and Healthcare Diagnostics
December 24, 2025 09:24 AM GMT| By Vivek SinghOverview of Verici Dx within the UK healthcare diagnostics sector, highlighting its FTSE AIM association and role in the broader UK equity market landscape.
Arecor Therapeutics Positioned Within FTSE AIM All-Share Biopharmaceutical Space
December 24, 2025 08:26 AM GMT| By Vivek SinghArecor Therapeutics operates in the UK biopharmaceutical sector and lies on the FTSE AIM All-Share, focusing on formulation technologies that support therapeutic development.
Inspiration Healthcare Group Positioned on FTSE AIM All-Share within UK Healthcare Devices
December 24, 2025 05:46 AM GMT| By Vivek SinghDetailed coverage of Inspiration Healthcare Group focusing on medical device operations, governance framework, and inclusion within the FTSE AIM All-Share index.
Convatec Group Positioned Within the FTSE 100 Medical Technology Landscape
December 24, 2025 05:28 AM GMT| By Vivek SinghConvatec Group operates as a UK-listed medical technology company included in FTSE 100 and FTSE 350, supporting healthcare delivery within the broader FTSE market framework.
FTSE AIM All-Share Context Frames Diaceutics in Healthcare Data Services
December 23, 2025 10:16 AM GMT| By Vivek SinghDetailed coverage of Diaceutics focusing on healthcare technology services, governance framework, and inclusion within the FTSE AIM All-Share in the UK market.
GSK within FTSE 100 Landscape Reflects UK Pharmaceutical Market Structure
December 23, 2025 07:25 AM GMT| By Vivek SinghDetailed coverage of GSK, focusing on UK pharmaceutical operations, governance framework, and inclusion within major FTSE market indices.
UK Equities Steady as FTS100 Today Reflects Currency and GDP Signals
December 22, 2025 11:18 AM GMT| By Vivek SinghUK shares showed steady alignment as sterling movements and economic data shaped sector trends across major FTSE indices without structural change.
London stocks narrative amid FTSE Today benchmarks and global cues
December 22, 2025 11:12 AM GMT| By Vivek SinghAn in-depth overview of UK equity markets, highlighting sector dynamics, global influences, and the role of FTSE benchmarks in shaping London trading activity.
Spire Healthcare Group plc within FTSE 350 healthcare services landscape
December 22, 2025 09:28 AM GMT| By Vivek SinghSpire Healthcare Group plc operates in the healthcare services sector, managing hospital and clinical operations while maintaining inclusion within the FTSE 350 framework.
Craneware healthcare technology profile within ftse-aim-100-index landscape
December 18, 2025 01:39 PM GMT| By Vivek SinghCraneware operates in healthcare technology and is listed on AIM as a constituent of the ftse-aim-100-index within the FTSE UK market structure.
Smith and Nephew (LON:SN) positioned across FTSE 100 Today healthcare landscape
December 18, 2025 11:44 AM GMT| By Vivek SinghSmith and Nephew remains an established healthcare equipment company within FTSE 100 and FTSE 350 indices following a banking reassessment under a sector performance view.
Poolbeg Pharma within FTSE AIM Focus on Clinical Progress and Research Direction
December 18, 2025 11:34 AM GMT| By Vivek SinghPoolbeg Pharma operates within the UK biopharmaceutical sector, advancing immune-focused research programmes while maintaining an AIM listing and index association.
UK Life Sciences Visibility Expands as SkinBioTherapeutics Aligns with FTSE AIM All-Share
December 18, 2025 11:25 AM GMT| By Vivek SinghSkinBioTherapeutics operates within the UK life sciences sector, maintaining microbiome-focused research activity and AIM market visibility through the FTSE AIM All-Share Index.
Veterinary Pharmaceuticals Focus as Animalcare Group Aligns with FTSE Market Structure
December 16, 2025 05:12 PM GMT| By Vivek SinghAnimalcare Group Plc operates within the UK veterinary pharmaceuticals sector, with established financial disclosures, defined market presence, and alignment with recognised FTSE index frameworks.
EKF Diagnostics and Its Healthcare Operations Across FTSE AIM Landscape
December 16, 2025 10:06 AM GMT| By Vivek SinghEKF Diagnostics operates within the healthcare diagnostics sector and maintains visibility on the FTSE AIM market through structured corporate communication.
RUA Life Sciences (LSE:RUA) Positioned Within FTSE AIM All-Share Medical Technology Framework
December 16, 2025 09:43 AM GMT| By Vivek SinghRUA Life Sciences operates within the medical technology sector, delivering polymer-based healthcare solutions while maintaining its position on the FTSE AIM All-Share index.
Genflow Biosciences (LSE:GENF) Positioned Within FTSE Biotechnology Landscape
December 16, 2025 09:15 AM GMT| By Vivek SinghGenflow Biosciences operates within the biotechnology sector, advancing gene therapy research while maintaining its position on the FTSE AIM All-Share index.
AstraZeneca update within FTSE 350 and FTSE 100 healthcare landscape
December 16, 2025 08:27 AM GMT| By Vivek SinghAstraZeneca receives European clearance for a subcutaneous immunology therapy, reinforcing its healthcare sector role within major UK indices and highlighting evolving treatment delivery approaches.
